Understanding functional status in people with interstitial lung disease
LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease - the SUNSET Study
This study is trying to understand how interstitial lung disease affects people's daily activities and overall health, while also looking at what factors might make it worse.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Aveiro University Academic / other |
| Locations | 1 site (Aveiro) |
| Trial ID | NCT06317831 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize the functional status of individuals with interstitial lung disease (ILD) and explore the factors contributing to its decline. It will assess the measurement properties of functional status instruments and gather participants' perspectives through interviews. The study also seeks to track the progression of functional status in ILD patients and develop a multidimensional index to predict mortality based on functional status parameters. Participants will be recruited from several hospitals in Portugal, focusing on a comprehensive assessment of their clinical and sociodemographic characteristics.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with any type of interstitial lung disease and are fluent in Portuguese.
Not a fit: Patients with other respiratory diseases, significant cognitive impairment, or other serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient-centered care and better management strategies for individuals with interstitial lung disease.
How similar studies have performed: Other studies have recognized the importance of functional status in ILD, but this specific approach to characterizing and predicting outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years * Diagnosed with any type of ILD * Fluent in Portuguese * Able to provide informed consent. Exclusion Criteria: * Other respiratory diseases * A history of acute cardiac/respiratory condition in the previous month * Present signs of cognitive impairment * Significant cardiovascular, neurological and/or musculoskeletal disease that may limit their participation * Current neoplasia * Other autoimmune diseases (aside from ID).
Where this trial is running
Aveiro
- University of Aveiro — Aveiro, Portugal (Recruiting)
Study contacts
- Principal investigator: Alda S. Marques, PhD — School of Health Sciences of the University of Aveiro (ESSUA)
- Study coordinator: Alda S. Marques, PhD
- Email: amarques@ua.pt
- Phone: 00351 234 372 462
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.